Emily Strauss, clinical professor of law at Duke University, joins the Business Scholarship Podcast to discuss her article Is Everything Securities Fraud?. In this article, Strauss analyzes the extent to which corporate harms to non-shareholders—such as victims of oil spills, tainted medicines, or defective automobiles—come to serve as the basis for securities litigation. Based on her findings, she concludes that this event-driven securities litigation could have deterrent effects but is likely a suboptimal mechanism for mitigating harms to non-shareholder victims of corporate misconduct.